Cipla Voluntarily Recalls Batches Of Coryx Throat Spray
Cipla Voluntarily Recalls Batches Of Coryx Throat Spray. Cipla Medpro (Pty) Ltd, in collaboration with the South African Health Products Regulatory Authority (SAHPRA), is recalling batches of Coryx Throat Spray (registration number W/16.3/58).
They are recalling the following batches of Coryx Throat Spray (registration number W/16.3/58):
The reason for the Class I Type A product recall is due to the possibility of the spray nozzle detaching from the spray mechanism during use resulting in the spray nozzle being ingested or getting stuck in the throat after detaching. People who purchased any of these batches of Coryx Throat Spray are requested to return it to their pharmacy, and they will be refunded the purchase price.
The Chief Executive Officer of Cipla South Africa, Paul Miller, said in a statement, “The safety and well-being of our patients is our utmost priority. Therefore, after liaising with SAHPRA, it was deemed necessary to recall specific batches of this product from the market. We are working closely with spray mechanism manufacturers to ensure there is no margin for error in future.”
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. It’s portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally.
